Navigation Links
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
Date:7/24/2014

orward to working with our partner PharmaEssentia to initiate the clinical trials of KX2-391 Ointment for psoriasis, and oral KX2-391 for leukemia and other oncology indications."

About Kinex:

Kinex Pharmaceuticals is a Buffalo, New York based company with additional offices in Cranford, New Jersey, Taipei, Taiwan and Hong Kong.  In addition to KX2-391 Ointment, the Company has four oral oncology drugs currently in clinical stages of development.  Two programs have emerged from collaboration with Hanmi Pharmaceuticals on the Orascovery Platform including Oraxol (oral paclitaxel) and Oratecan (oral irinotecan). Internally discovered compounds include KX2-391 for oncology indications and KX2-361 for glioma which was also been granted orphan drug designation.

Kinex is developing its pipeline globally through partnerships with: Hanmi Pharmaceuticals (Seoul, Korea), Xiangxue Pharmaceuticals (Guangzhou, China), PharmaEssentia Corporation (Taipei, Taiwan) and Zenith Technology (Dunedin, New Zealand). Kinex is also working on additional Orascovery-based drug candidates in collaboration with Hanmi Pharmaceuticals and some of the projects received research funding support from the Innovation and Technology Commission (ITC) of the Government of the Hong Kong Special Administrative Region through Kinex Pharmaceuticals (HK) Limited* and the support of the Department of Applied Biology and Chemical Technology of the Hong Kong PolyTechnic University.

*Any opinions, findings, conclusions or recommendations expressed in this material do not reflect the views of the Government of the Hong Kong Special Administrative Region, the Innovation and Technology Commission or the Small Entrepreneur Research Assistance Programme Project Assessment Panel.

Website:
'/>"/>

SOURCE Kinex Pharmaceuticals
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kinex Pharmaceuticals Announced that the U.S. Food and Drug Administration has Granted Orphan Drug Status to KX02 for the Treatment of Gliomas
2. Kinex Announces First Patient Dosed in Phase Ib Study of Oraxol, an Orally Dosed Paclitaxel
3. Hanmi Pharmaceuticals to Assign the Rights to Five New Territories to Kinex as Part of the Orascovery Program Strategic Plan
4. Dr. David Hangauer, Chief Scientific Officer and Co-Founder, commits his career to Kinex Pharmaceuticals
5. Kinex Receives Research Support from the Hong Kong Innovation and Technology Commission (ITC)
6. Kinex Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel that is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US
7. Kinex Pharmaceuticals Will Take the Lead in the Orascovery Program Development in China
8. Kinex Announces that the US FDA Allows their IND to Begin KX02 Clinical Trials
9. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
10. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
11. Hanmi and Kinex Announced Korean FDA Allowance of the KX01 IND Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015 OpportunityAnalyzer: Sepsis - ... Sepsis patients suffer from a series of diverse complications ... in the blood or tissues, which cause a rapidly ... to mortality rates near 50% depending on disease severity. ... healthcare systems of the global marketplace, which for the ...
(Date:5/27/2015)... -- PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - ... Event-Driven Update Summary The lupus therapeutics ... the only drug that has gained marketing approval for ... patients, uptake has remained low, but due to its ... lupus market in terms of value and is currently ...
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "Asia Pacific Ultrasound Devices ... - 2019)"  company profile to their ... , ,Ultrasound is a type of imaging. ... at body parts and structures inside the ...
Breaking Medicine Technology:OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3Asia Pacific Ultrasound Devices Market Report 2015 - Growth, Trends And Forecasts 2014 - 2019 2
... Meg Porfido, former chief human resources officer for Level ... Directors for Kaiser Foundation Hospitals and Kaiser Foundation Health ... to our Board will further diversify the outstanding talents ... George C. Halvorson, chairman and chief executive officer of ...
... 2011 Varian Medical Systems (NYSE: VAR ... system vendors in a 2011 performance report released last ... monitoring and reporting on the performance of healthcare technology ... a range of clinical, administrative, and financial activities in ...
Cached Medicine Technology:Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 2Kaiser Foundation Hospitals and Health Plan Appoints Meg Porfido to Its Board of Directors 3Varian Medical Systems' ARIA Ranked No. 1 in 2011 KLAS Report on Oncology IT Vendors 2Varian Medical Systems' ARIA Ranked No. 1 in 2011 KLAS Report on Oncology IT Vendors 3
(Date:5/27/2015)... Nursing Homes are starting to supplant hospitals as focus of ... April 2015 New York Times article. While Americans, in practice, ... years of research have documented the risks of hospitalization for ... both safer for older patients and less costly than hospitals. ... patients and family members may worry whether a nursing home ...
(Date:5/27/2015)... May 27, 2015 With the launch ... more robust Network Management Module (NMM) tool, monitoring provider-network ... 21 issue of Atlantic Information Services, Inc.’s (AIS) Medicare ... NMM tool, as well as analysis from industry experts ... The changes coming to the NMM were announced at ...
(Date:5/27/2015)... Marcos, CA (PRWEB) May 27, 2015 Allred ... solution to help patients - who need extensive dental treatment ... well as treatment options customized for their problems. , Dr. ... in a visual presentation of the assessment of the patient’s ... suitable options, which can treat their oral health problems. , ...
(Date:5/27/2015)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a leading ... announced today that SanMar Corporation successfully implemented the ... and point tracking processes for over 3,000 employees ... , Family-owned since 1971, Seattle-based SanMar Corporation is ... and mill brands. SanMar supplies apparel and accessories ...
(Date:5/27/2015)... 2015 CURE® Magazine and ... mission is to advance research, provide information and support, ... to battle the fifth most common type of cancer, ... start to grow out of control. , “CURE ... every stage of the cancer experience through digital and ...
Breaking Medicine News(10 mins):Health News:BestNursingHomes.com Launches on National Senior Health and Fitness Day 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 2Health News:AIS Newsletter Offers Coverage, Analysis of New CMS Strategy on Monitoring MA Provider Access 3Health News:San Marcos Dentistry Office Offering a New Service Dental Case Planning 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 2Health News:SanMar Corporation Successfully Implemented NOVAtime Workforce Management Solution across 9 locations 3Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 2Health News:CURE® Magazine and Bladder Cancer Advocacy Network Align to Increase Awareness of Fifth Most Common Type of Cancer 3
... perform with, it would be British band Coldplay. ... and that's why he would give an arm and a leg ... Timberlake knows just who he wants to jam with - Gwyneth ... so I'd love to do a duet with them - especially ...
... systems have been deployed worldwide to provide early detection ... ,New methods that improve the overall detection capabilities ... However, most surveillance systems do not hold up when ... caused by public-health crises and major public events, such ...
... and Hull York Medical School has confirmed a link between ... is a vitamin that comes from vegetables such as spinach ... sunflower seeds as well as liver are rich sources of ... to bread or flour will decrease the number of babies ...
... shows that the work intended for global health is ... ,The research was conducted by a UW team including ... the School of Public Health and Community Medicine; Jennifer ... Weatherford, finance and administration director of the Department of ...
... of alcohol has found that a high percentage of ... youth .Many high school students consume alcohol both regularly ... sources of alcohol, individuals who illegally provide alcohol to ... ,Many types of social sources of alcohol are used ...
... review shows how nicotine patches can double ... that the antidepressants bupropion and nortriptyline aid long-term ... (e.g. fluoxetine) do not. ,Yet another ... UK by NICE), increased the odds of successful ...
Cached Medicine News:Health News:Global Health Enriching the States Economy 2Health News:Underage Youth Get Alcohol from Social Sources 2Health News:Underage Youth Get Alcohol from Social Sources 3
... mid-sized chest freezer utilizes ultra-thin vacuum ... capacity without increasing the footprint. Patented ... extends compressor life. Bright LED display ... provided for remote user-supplied monitoring system. ...
... NU-5510 DHD AutoFlow Direct Heat Decontamination ... guarantying the greatest control of airborne ... at 95C wet decontamination and a ... useful for cell line changes and ...
... ultra-thin vacuum insulation panel technology, in ... increase storage capacity, while maintaining a ... or 3,336 samples. Patented heat accumulator ... and extends compressor life. Temperature and ...
... Advanced Series CO2 Incubators ... reliability. Microprocessor achieves precise temperature ... natural evaporation & RH% is ... CO2 and RH are displayed ...
Medicine Products: